ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $46,718,000 | +220.5% | 2,477,066 | +100.0% | 0.34% | +56.8% |
| Q2 2019 | $14,578,000 | -13.8% | 1,238,533 | 0.0% | 0.22% | -33.7% |
| Q1 2019 | $16,906,000 | +33.2% | 1,238,533 | 0.0% | 0.33% | +62.0% |
| Q4 2018 | $12,695,000 | -38.4% | 1,238,533 | 0.0% | 0.20% | -21.8% |
| Q3 2018 | $20,622,000 | +5.4% | 1,238,533 | 0.0% | 0.26% | +1.9% |
| Q2 2018 | $19,569,000 | +24.4% | 1,238,533 | 0.0% | 0.26% | +8.4% |
| Q1 2018 | $15,729,000 | +10.9% | 1,238,533 | 0.0% | 0.24% | +8.7% |
| Q4 2017 | $14,181,000 | -6.5% | 1,238,533 | 0.0% | 0.22% | -11.4% |
| Q3 2017 | $15,172,000 | +7.0% | 1,238,533 | 0.0% | 0.25% | +27.5% |
| Q2 2017 | $14,181,000 | -45.0% | 1,238,533 | 0.0% | 0.19% | -37.9% |
| Q1 2017 | $25,761,000 | 0.0% | 1,238,533 | 0.0% | 0.31% | +11.9% |
| Q4 2016 | $25,761,000 | -36.5% | 1,238,533 | 0.0% | 0.28% | -32.2% |
| Q3 2016 | $40,587,000 | +31.2% | 1,238,533 | 0.0% | 0.41% | +20.9% |
| Q2 2016 | $30,926,000 | +2.0% | 1,238,533 | 0.0% | 0.34% | +12.6% |
| Q1 2016 | $30,332,000 | -25.9% | 1,238,533 | 0.0% | 0.30% | +1.7% |
| Q4 2015 | $40,909,000 | +0.8% | 1,238,533 | 0.0% | 0.30% | +51.0% |
| Q3 2015 | $40,574,000 | -38.2% | 1,238,533 | 0.0% | 0.20% | -35.3% |
| Q2 2015 | $65,605,000 | -8.7% | 1,238,533 | -50.2% | 0.30% | -16.5% |
| Q1 2015 | $71,819,000 | – | 2,488,533 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |